Skip to main content
Go to the University of Minnesota Twin Cities home page
  • One Stop
  • MyU

Federal Executive Orders & Other Directives

University leaders are monitoring federal changes and executive orders that could affect research projects and programs (updated 12/15/25): z.umn.edu/fed-impacts

Research & Innovation Office

Office of Biotechnology Activities Oversight

Contact Us
Menu
  • About Us
    • Office of Biotechnology Activities Oversight
    • Contact Us
  • eProtocol
  • Research Oversight Areas
    • Institutional Biosafety Committee (IBC)
    • Stem Cell Research Oversight (SCRO)
    • Clinical Trials and the IBC
    • Fetal Tissue Research (FTR)
    • Dangerous Gain of Function (dGOF)
      • Dangerous Gain of Function (dGOF) Overview
  • Institutional Biosafety Committee
    • IBC Oversight
    • IBC Application Process & General Info
      • General Recommendations
      • Minimal Risk Application Guidelines
      • New IBC Protocols & Renewals
      • IBC Applications for Teaching Laboratories
      • Amendments to IBC Applications
      • Annual Continuing Reviews
      • Post Submission Process
      • Post Review Process
      • Post Approval Process
      • Risk Assessment & Biosafety Containment Levels
      • IBC Guidance for Core Facilities
      • Shipment of r/sNA Contained in Organisms or Viral Genomes
      • Poliovirus Containment
    • IBC Meeting & Submission Deadlines
    • Application Sections
      • Personnel Information
      • Activities Include
      • Funding
      • Study Objectives
      • r/sNA
      • Biological Toxins
      • Infectious Agents
      • Human Clinical Trials
      • Genetic Modification of Animals
      • Safety
      • Attachments
      • Assurance
      • Check for Completeness
      • Submit Form
    • IBC Committee
    • IBC Policies
  • Incident Reporting
  • Training & Education
    • IBC Training & Educational Resources
    • Stem Cell Research Oversight (SCRO)
    • Human Gene Transfer (HGT)
    • Dual Use Research for Concern (DURC)
    • Fetal Tissue Research (FTR)

Breadcrumb

  1. OBAO
  2. Fetal Tissue Research (FTR)

Fetal Tissue Research (FTR)

Educational Resources

  • University administrative policy on procuring and using human fetal tissue for transplantation research
  • Preparing to Conduct Human Fetal Transplantation Research Ineligible for Federal/State Funding
  • Procuring and Using Human Fetal Tissue for Research (Non-Transplantation)
  • Conducting Research Using Human Fetal Tissue for Transplantation into Designated Recipients

Office of Biotechnology Activities Oversight

Suite 280 McNamara Alumni Center
200 Oak Street S.E.
Minneapolis, MN 55455
United States

[email protected] (612) 626-2161
  • Contact Us
University of Minnesota wordmark; Research & Innovation Office

Announcements for the UMN Research Community

Sign up for the UMN Research newsletter

SYSTEM CAMPUSES

System Website

Crookston

Duluth

Morris

Rochester

Twin Cities

For Students, Faculty, and Staff

  • One Stop
  • MyU
© 2026 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement | Report Web Disability-Related Issues
  • About Us
    • Office of Biotechnology Activities Oversight
    • Contact Us
  • eProtocol
  • Research Oversight Areas
    • Institutional Biosafety Committee (IBC)
    • Stem Cell Research Oversight (SCRO)
    • Clinical Trials and the IBC
    • Fetal Tissue Research (FTR)
    • Dangerous Gain of Function (dGOF)
      • Dangerous Gain of Function (dGOF) Overview
  • Institutional Biosafety Committee
    • IBC Oversight
    • IBC Application Process & General Info
      • General Recommendations
      • Minimal Risk Application Guidelines
      • New IBC Protocols & Renewals
      • IBC Applications for Teaching Laboratories
      • Amendments to IBC Applications
      • Annual Continuing Reviews
      • Post Submission Process
      • Post Review Process
      • Post Approval Process
      • Risk Assessment & Biosafety Containment Levels
      • IBC Guidance for Core Facilities
      • Shipment of r/sNA Contained in Organisms or Viral Genomes
      • Poliovirus Containment
    • IBC Meeting & Submission Deadlines
    • Application Sections
      • Personnel Information
      • Activities Include
      • Funding
      • Study Objectives
      • r/sNA
      • Biological Toxins
      • Infectious Agents
      • Human Clinical Trials
      • Genetic Modification of Animals
      • Safety
      • Attachments
      • Assurance
      • Check for Completeness
      • Submit Form
    • IBC Committee
    • IBC Policies
  • Incident Reporting
  • Training & Education
    • IBC Training & Educational Resources
    • Stem Cell Research Oversight (SCRO)
    • Human Gene Transfer (HGT)
    • Dual Use Research for Concern (DURC)
    • Fetal Tissue Research (FTR)